Skip to main content

Security report for pharmeca.cz

Pharmeca a.s. · Healthcare · Czech Republic

Medium risk. 7 critical or high findings in GDPR outside view, Security headers and 1 other check.

Security score

50/100

Risk levelMedium

0–100, higher is better. How it is calculated

Pharmeca a.s. is a Czech Republic-based specialist company providing expert consulting and analytical services in the pharmaceutical and healthcare sectors. Their core offerings include pricing and reimbursement dossier preparation, pharmacoeconomic and biostatistical analyses, market access strategy consulting, and healthcare data analytics. The company targets pharmaceutical firms, healthcare product holders, and regulatory professionals, positioning itself as a trusted partner with long-standing industry experience since at least 2012. The website is professionally designed, content-rich, and GDPR compliant, reflecting a mature digital presence. Technically, the site uses modern analytics tools such as Google Analytics and Plausible, employs Google reCAPTCHA for form security, and implements cookie consent with an opt-in mechanism. However, there is room for improvement in security headers and incident response transparency. The WHOIS data is unavailable, which slightly impacts domain trustworthiness, but the overall business credibility remains high based on website content and contact information.

Scanned

NIS2 and GDPR posture

GDPR outside view
40/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching pharmeca.cz

This scan found 26 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
15
Email security
60
DNS health
80
Network security
40
GDPR outside view
40
Average
50

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention pharmeca.cz, from OffSeq Breach.

No leaked records found

Breach holds no records for pharmeca.cz right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Pharmeca a.s. operates in the healthcare consulting sector with a focus on pharmaceutical market access and pricing strategies. Their competitive advantage lies in multidisciplinary expertise combining medical, pharmaceutical, economic, legal, and statistical knowledge. The business model revolves around providing tailored consulting, detailed analyses, and regulatory support to pharmaceutical companies and healthcare stakeholders. Revenue streams likely include consulting fees, premium newsletter subscriptions, and training services. The company maintains a professional partnership ecosystem and offers transparent contact channels. Growth indicators include active content updates, interactive data visualizations, and a comprehensive newsletter offering. The absence of WHOIS data suggests a need for improved domain transparency but does not detract from operational legitimacy.

Security posture

The website demonstrates a solid security posture with HTTPS enforced, use of Google reCAPTCHA on forms to prevent automated abuse, and a cookie consent mechanism aligned with GDPR requirements. IP anonymization in Google Analytics further supports privacy compliance. However, the absence of visible HTTP security headers such as Content Security Policy, HSTS, and X-Frame-Options indicates potential areas for enhancement. No vulnerabilities or exposed sensitive data were detected in the content. The lack of published security policies or incident response contacts suggests limited transparency in security governance. Overall, the security maturity is good but could benefit from formalized policies and technical header implementations.

Recommendations

  1. Implement HTTP security headers including Content Security Policy, HSTS, X-Frame-Options, and X-XSS-Protection to enhance protection against common web attacks.
  2. Publish a security policy and incident response contact information on the website to improve transparency and preparedness.
  3. Add a security.txt file to facilitate responsible vulnerability disclosure.
  4. Regularly audit third-party scripts and libraries to ensure no vulnerabilities are introduced.
  5. Consider enhancing accessibility features to improve compliance and user experience.

Contact details published on the site

Addresses
Legal name
Pharmeca a.s.
Registration number
B 18221
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Pharmeca a.s.
Description
Pharmeca a.s. is a specialist company in the field of pharmacy and medical devices, providing professional pricing and reimbursement analyses along with market knowledge to assist in setting effective commercial strategies for products.
Key services
Pricing and reimbursement dossier preparation, Pharmacoeconomic and biostatistical analyses, Market access strategy consulting, Healthcare data analytics, Regulatory and legal advisory, In-house training and seminars
Content quality
excellent
Branding
consistent

Technology

Stack
jQuery, Google Analytics (gtag.js), Google reCAPTCHA, Plausible Analytics, Cookie Consent by Silktide
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Use of Google reCAPTCHA on forms
  • Cookie consent with opt-in mechanism
  • Anonymize IP in Google Analytics

Analytics and tracking

Services
Google Analytics, Plausible Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Plausible Analytics
Marketing tools
Newsletter subscription, Cookie consent plugin
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content in Czech language.
  2. Strong focus on pharmaceutical and healthcare consulting services.
  3. Comprehensive privacy and cookie policies with GDPR compliance.
  4. Use of modern analytics and consent management tools.
  5. No visible security headers detected in provided data; opportunity for improvement.
  6. WHOIS data unavailable, which may impact domain trust evaluation.
  7. No social media links found on the site.
  8. Multiple newsletter subscription options including free and premium.
  9. Clear contact information with phone, email, and physical address.
  10. No signs of adult or questionable content.
Technical notes

Notes

The website uses a modern technology stack including jQuery, Google Analytics, Plausible Analytics, Google reCAPTCHA, and a cookie consent plugin. The site is well-structured with proper meta tags for SEO and mobile responsiveness. Performance is moderate, with potential for optimization. No CMS was explicitly detected, suggesting a custom or static site build. Hosting provider details are not available. The site includes interactive data visualizations and newsletter subscription forms with CSRF tokens and honeypot fields for spam prevention. Overall, the technical implementation is solid with opportunities to improve security headers and accessibility compliance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with pharmeca.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review pharmeca.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.